ONC Q4 2019 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$32B

Q4 2019 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$57M-3.0% YoY

Gross Profit

$39M68.4% margin

Operating Income

-$388M-682.1% margin

Net Income

-$388M-682.1% margin

EPS (Diluted)

$-6.37

QoQ Revenue Growth

+13.5%

Cash Flow

Operating Cash Flow

-$267M

Free Cash Flow

-$303M

Stock-Based Comp.

$38M

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$634M

Stockholders' Equity

$962M

Cash & Equivalents

$618M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$57M	$59M	-3.0%
Gross Profit	$39M	-$208M	+118.7%
Operating Income	-$388M	-$281M	-38.2%
Net Income	-$388M	-$268M	-44.7%